Comparison of epoetin alfa and darbepoetin alfa biological activity under different administration schedules in normal mice

被引:14
|
作者
Sasu, BJ [1 ]
Hartley, C [1 ]
Schultz, H [1 ]
McElroy, P [1 ]
Khaja, R [1 ]
Elliott, S [1 ]
Egrie, JC [1 ]
Browne, JK [1 ]
Begley, CG [1 ]
Molineux, G [1 ]
机构
[1] Amgen Inc, Dept Hematol, Thousand Oaks, CA 91320 USA
关键词
Aranesp (R); darbepoetin alfa; epoetin alfa; erythropoietic units; hemoglobin;
D O I
10.1159/000084446
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The unit of erythropoietic activity has long been the standard by which erythropoietic agents are judged, but the development of long-acting agents such as darbepoetin alfa has highlighted the shortcomings of this approach. To this point, we compared the in vivo activity of Epoetin alfa and darbepoetin alfa per microgram of protein core. Using the established mass-to-unit conversion for Epoetin alfa (1 mu g congruent to 200 U), we then calculated darbepoetin alfa activity in units. Activity varied with treatment regimen (1 mu g darbepoetin alfa congruent to 800 U for 3 times weekly dosing to 8,000 U for a single injection). This analysis reveals the inadequacy of evaluating darbepoetin alfa activity in terms of standard erythropoietic units. We therefore propose that for molecules with heightened biological activity, a more legitimate basis for comparison is the protein mass. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:163 / 174
页数:12
相关论文
共 50 条
  • [21] Comparison of epoetin alfa and darbepoetin alfa doses routinely used in clinical practice in Department of Defense beneficiaries
    Cota, J. M.
    Bretzke, D. R.
    Allerman, A. A.
    Meade, D. J.
    Trice, S.
    VALUE IN HEALTH, 2007, 10 (03) : A154 - A154
  • [22] Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysis
    McMahon, LP
    Chester, K
    Walker, RG
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (03) : 509 - 516
  • [23] A COMPARISON OF IV EPOETIN-ALFA (EPREX) AND DARBEPOETIN-ALFA (ARANESP) IN HAEMODIALYSIS PATIENTS IN THE PILBARA DIALYSIS UNIT
    Irish, A.
    Cochrane, R.
    NEPHROLOGY, 2007, 12 : A20 - A20
  • [24] Comparison of epoetin alfa (EPO) and darbepoetin alfa (DARB) utilization in cancer chemotherapy patients treated in a hospital outpatient setting
    Vekeman, F.
    LaFeuille, M.
    Bailey, R.
    Piech, C. Tak
    McKenzie, R. S.
    Lefebvre, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA OUTPATIENTS
    Lafeuille, M. H.
    Bailey, R. A.
    Senbetta, M.
    McKenzie, R. S.
    Lefebvre, P.
    VALUE IN HEALTH, 2011, 14 (03) : A160 - A160
  • [26] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN A CHRONIC KIDNEY DISEASE POPULATION TREATED IN THE HOSPITAL OUTPATIENT SETTING
    Vekeman, Francis
    McKenzie, R. Scott
    Lafeuille, Marie-Helene
    Bailey, Robert A.
    Piech, Catherine Tak
    Lefebvre, Patrick
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A78 - A78
  • [27] DOSING PATTERN AND COST COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA INPATIENTS
    Lafeuille, M. H.
    Bailey, R. A.
    Senbetta, M.
    McKenzie, R. S.
    Lefebvre, P.
    VALUE IN HEALTH, 2011, 14 (03) : A161 - A161
  • [28] Comparison of hemoglobin response in hospitalized hemodialysis patients receiving either epoetin alfa or darbepoetin alfa in an integrated health care system
    Lew, I
    Adamson, R
    PHARMACOTHERAPY, 2004, 24 (10): : 1446 - 1447
  • [29] A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia
    Steensma, David P.
    Dakhil, Shaker R.
    Novotny, Paul J.
    Sloan, Jeff A.
    Johnson, David B.
    Anderson, Daniel M.
    Mattar, Bassam I.
    Moore, Dennis F., Jr.
    Nikcevich, Daniel
    Loprinzi, Charles L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (10) : 877 - 881
  • [30] A Randomized Comparison of Standard Weekly Epoetin Alfa to Every-3-Week Epoetin Alfa and Every-3-Week Darbepoetin Alfa: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC)
    Steensma, David P.
    Dakhil, Shaker R.
    Novotny, Paul J.
    Sloan, Jeff A.
    Johnson, David B.
    Anderson, Daniel. M.
    Mattar, Bassani I.
    Moore, Dennis F., Jr.
    Nikcevich, Daniel
    Loprinzi, Charles L.
    BLOOD, 2009, 114 (22) : 1172 - 1172